Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Xiao, Lei ^a,d   Ornatowska, Magdalena ^a   Zhao, Guiqing ^a   Cao, Hongmei ^a   Yu, Rui ^a   Deng, Jing ^a   Li, Yongchao ^a   Zhao, Qiong ^b   Sadikot, Ruxana T ^c   Christman, John W ^a,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN D2; PROSTAGLANDIN E; PROSTAGLANDIN E SYNTHASE 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; INFLAMMATION; MACROPHAGE; MICROSOME; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STABLE EXPRESSION; UPREGULATION;

4-BUTYROLACTONE; ANIMALS; CYCLOOXYGENASE 1; DINOPROSTONE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROSOMES; NITRIC OXIDE SYNTHASE TYPE II; PRIMARY CELL CULTURE; PROSTAGLANDIN D2; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; THIOPHENES; TRANS-ACTIVATORS;

EID: 84870613866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050244     Document Type: Article

References (46)

1. Funk CD, (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
2. Hata AN, Breyer RM, (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103: 147-166.
3. Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA, (1999) Arachidonic acid oxygenation by COX-1 and COX-2: Mechanisms of catalysis and inhibition. J Biol Chem 274: 22903-22906.
4. Cao H, Xiao L, Park G, Wang X, Azim AC, et al. (2008) An improved LC-MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluids. Anal Biochem 372: 41-51.
5. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, et al. (2002) Cyclooxygenase-1 is up-regulated in cervical carcinomas. Cancer Res 62: 424-432.
6. Simmons DL, Botting RM, Hla T, (2004) Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437.
7. Samuelsson B, Morgenstern R, Jakobsson PJ, (2007) Membrane prostaglandin E synthase-1: A novel therapeutic target. Pharmacol Rev 59: 207-224.
8. Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ, (2004) Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor γ. Cancer Res 64: 1181-1189.
9. Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, et al. (2002) Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105: 1816-1823.
10. Li X, Afif H, Cheng S, Martel-Pelletier J, Pelletier JP, et al. (2005) Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. J Rheumatol 32: 887-895.
11. Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H, (2008) Correlation between the prostaglandin D2/E2 ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int 57: 429-436.
12. Scher JU, Pillinger MH, (2009) The anti-inflammatory effects of prostaglandins. J Investig Med 57: 703-708.
13. Montuschi P, Toni GC, Paredi P, Pantelidis P, du Bois RM, et al. (1998) 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 158: 1524-1527.
14. Peebles RS Jr, Hashimoto K, Morrow JD, Dworski R, Collins RD, et al. (2002) Selective cyclooxygenase-1 and-2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 165: 1154-1160.
15. Wenzel SE, Westcott JY, Smith HR, Larsen GL, (1989) Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 139: 450-457.
16. Sastre B, Fernandez-Nieto M, Molla R, Lopez E, Lahoz C, et al. (2008) Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis. Allergy 63: 58-66.
17. Urade Y, Fujimoto N, Hayaishi O, (1985) Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 260: 12410-12415.
18. Kanaoka Y, Ago H, Inagaki E, Nanayama T, Miyano M, et al. (1997) Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 90: 1085-1095.
19. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B, (1999) Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220-7225.
20. Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, et al. (2003) Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and-2. J Biol Chem 278: 37937-37947.
21. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I, (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275: 32775-32782.
22. Mancini JA, Blood K, Guay J, Gordon R, Claveau D, et al. (2001) Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J Biol Chem 276: 4469-4475.
23. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, et al. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792.
24. Herlong JL, Scott TR, (2006) Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol Lett 102: 121-131.
25. Thomas S, Zhao G, Yu R, Deng J, Christman JW, et al. (2011) Critical role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in mouse bone marrow-derived macrophages. Am J Respir Crit Care Med 183: A1076.
26. Dahl R, Simon MC, (2003) The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells Mol Dis 31: 229-233.
27. Karpurapu M, Wang X, Deng J, Park H, Xiao L, et al. (2011) Functional PU.1 in macrophages has a pivotal role in NFγB activation and neutrophilic lung inflammation during endotoxemia. Blood 118: 5255-5266.
28. Jorens PG, Matthys KE, Bult H, (1995) Modulation of nitric oxide synthase activity in macrophages. Mediators Inflamm 4: 75-89.
29. Raetz CR, Garrett TA, Reynolds CM, Shaw WA, Moore JD, et al. (2006) Kdo2-lipid A of escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J Lipid Res 47: 1097-1111.
30. Yu R, Xiao L, Zhao G, Christman JW, van Breemen RB, (2011) Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. J Pharmacol Exp Ther 339: 716-725.
31. Cao H, Yu R, Tao Y, Nikolic D, van Breemen RB, (2011) Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 54: 230-235.
32. Deng J, Wang X, Qian F, Vogel S, Xiao L, et al. (2012) Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression. J Immunol 188: 5734-5740.
33. Xiao L, Pimental DR, Amin JK, Singh K, Sawyer DB, et al. (2001) MEK1/2-ERK1/2 mediates α1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 779-787.
34. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, et al. (2002) Role of reactive oxygen species and NAD(P)H oxidase in α1-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282: C926-C934.
35. Xiao L, Zhao Q, Du Y, Yuan C, Solaro RJ, et al. (2007) PKCε increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo. Biochemistry 46: 7054-7061.
36. Ornatowska M, Azim AC, Wang X, Christman JW, Xiao L, et al. (2007) Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 293: L1377-L1384.
37. Guerrero MD, Aquino M, Bruno I, Terencio MC, Paya M, et al. (2007) Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression. J Med Chem 50: 2176-2184.
38. Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, et al. (1993) NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 24: 105-110.
39. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, et al. (1994) Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1209: 130-139.
40. Thoren S, Weinander R, Saha S, Jegerschold C, Pettersson PL, et al. (2003) Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J Biol Chem 278: 22199-22209.
41. Hume DA, Allan W, Fabrus B, Weidemann MJ, Hapel AJ, et al. (1987) Regulation of proliferation of bone marrow-derived macrophages. Lymphokine Res 6: 127-139.
42. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, et al. (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291: 884-889.
43. Takayama K, Sukhova GK, Chin MT, Libby P, (2006) A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circ Res 98: 499-504.
44. Medeiros AI, Serezani CH, Lee SP, Peters-Golden M, (2009) Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med 206: 61-68.
45. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD, (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690.
46. Goulet JL, Pace AJ, Key ML, Byrum RS, Nguyen M, et al. (2004) E-Prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 173: 1321-1326.